Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
329
datasets available to search
ShareScore release 0.9.0
Dataset results
329 results for “aflibercept”
Efficacy and Safety of RTH258 Versus Aflibercept - Study 1
ClinicalTrials.gov study NCT02307682. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
ClinicalTrials.gov study NCT04429503. IPD Sharing: YES. Countries: 8. Publications: 3.
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
ClinicalTrials.gov study NCT03917472. IPD Sharing: YES. Countries: 5. Publications: 1.
Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)
ClinicalTrials.gov study NCT01521559. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy
ClinicalTrials.gov study NCT01661270. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
ClinicalTrials.gov study NCT00519285. IPD Sharing: Not stated. Countries: 31. Publications: 3.
Aflibercept Injection for Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT01805297. IPD Sharing: NO. Countries: 1. Publications: 1.
Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors
ClinicalTrials.gov study NCT01782443. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma
ClinicalTrials.gov study NCT00794417. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov study NCT04126317. IPD Sharing: YES. Countries: 2. Publications: 1.
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept
ClinicalTrials.gov study NCT01617148. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov study NCT04522167. IPD Sharing: NO. Countries: 9. Publications: 1.
Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD
ClinicalTrials.gov study NCT02161575. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema
ClinicalTrials.gov study NCT01363440. IPD Sharing: Not stated. Countries: 1. Publications: 8.
A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT04450329. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01661972. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
ClinicalTrials.gov study NCT01882868. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO
ClinicalTrials.gov study NCT02800642. IPD Sharing: Not stated. Countries: 8. Publications: 1.
S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT00828139. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
ClinicalTrials.gov study NCT02581891. IPD Sharing: Not stated. Countries: 8. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.